AT204180B - Process for the preparation of therapeutically useful iron-polyisomaltosate complexes - Google Patents

Process for the preparation of therapeutically useful iron-polyisomaltosate complexes

Info

Publication number
AT204180B
AT204180B AT113358A AT113358A AT204180B AT 204180 B AT204180 B AT 204180B AT 113358 A AT113358 A AT 113358A AT 113358 A AT113358 A AT 113358A AT 204180 B AT204180 B AT 204180B
Authority
AT
Austria
Prior art keywords
polyisomaltosate
complexes
preparation
therapeutically useful
useful iron
Prior art date
Application number
AT113358A
Other languages
German (de)
Original Assignee
Hausmann Ag Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hausmann Ag Labor filed Critical Hausmann Ag Labor
Priority to AT113358A priority Critical patent/AT204180B/en
Application granted granted Critical
Publication of AT204180B publication Critical patent/AT204180B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/02—Dextran; Derivatives thereof
AT113358A 1958-02-17 1958-02-17 Process for the preparation of therapeutically useful iron-polyisomaltosate complexes AT204180B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT113358A AT204180B (en) 1958-02-17 1958-02-17 Process for the preparation of therapeutically useful iron-polyisomaltosate complexes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT113358A AT204180B (en) 1958-02-17 1958-02-17 Process for the preparation of therapeutically useful iron-polyisomaltosate complexes

Publications (1)

Publication Number Publication Date
AT204180B true AT204180B (en) 1959-07-10

Family

ID=3507301

Family Applications (1)

Application Number Title Priority Date Filing Date
AT113358A AT204180B (en) 1958-02-17 1958-02-17 Process for the preparation of therapeutically useful iron-polyisomaltosate complexes

Country Status (1)

Country Link
AT (1) AT204180B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1196629B (en) * 1961-11-30 1965-07-15 Hausmann Ag Labor Process for the production of nonionic, therapeutically usable ferric hydroxide-dextran complexes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1196629B (en) * 1961-11-30 1965-07-15 Hausmann Ag Labor Process for the production of nonionic, therapeutically usable ferric hydroxide-dextran complexes

Similar Documents

Publication Publication Date Title
CH411921A (en) Process for the preparation of aminoacetonitriles
CH372423A (en) Process for the production of solid preparations
CH400174A (en) Process for the preparation of urazole compounds
CH397677A (en) Process for the preparation of aroylalkylpiperidines
CH377839A (en) Process for the preparation of α-phenylbenzoyl-α-arylaminocarbinol derivatives
CH377363A (en) Process for the preparation of 5-aminopyrazoles
CH409892A (en) Process for the production of peroxo-monosulphates
CH408015A (en) Process for the preparation of 3-nitro-azacyclo-alkanone-2-N-carbochlorides
CH368897A (en) Process for the production of dye-rich preparations
CH390234A (en) Process for the production of Vinylthioäthylthiolphosph3r- or, -phosphonsäureestern
AT204180B (en) Process for the preparation of therapeutically useful iron-polyisomaltosate complexes
CH377358A (en) Process for the preparation of di-alkyleneimides
CH417104A (en) Process for the preparation of eupolyoxymethylenes
CH387645A (en) Process for the preparation of rhodantriazines
CH375362A (en) Process for the manufacture of 4-quinazolones
CH374655A (en) Process for the preparation of unsaturated 6-halo-3-keto-steroids
CH383960A (en) Process for the preparation of gonad-inhibiting derivatives of 17-epi-oestriol
CH374659A (en) Process for the preparation of 11-oxy-steroids
CH391723A (en) Process for the preparation of 3-aralkyl-2-tert-amino-alkyl-indenes
CH378312A (en) Process for the preparation of ethynyl-a- or -b-ionol
CH369133A (en) Process for the preparation of substituted tetrahydro-oxazines
CH372063A (en) Process for the preparation of 5-nitro-2-furfuryl nitrate
CH397672A (en) Process for the production of tetraorganodiphosphines
AT209335B (en) Process for the preparation of dioxopyrazolidines
AT240538B (en) Process for the preparation of 6α-fluoro-16-methylpregnenes and -pregnadienes